Zhang_2020_Evid.Based.Complement.Alternat.Med_2020_5129562

Reference

Title : Acupotomy Alleviates Energy Crisis at Rat Myofascial Trigger Points - Zhang_2020_Evid.Based.Complement.Alternat.Med_2020_5129562
Author(s) : Zhang Y , Du NY , Chen C , Wang T , Wang LJ , Shi XL , Li SM , Guo CQ
Ref : Evid Based Complement Alternat Med , 2020 :5129562 , 2020
Abstract :

The aim of this study was to determine the effects of acupotomy on energy crises in rat trigger points (TrPs) by measuring mechanical pain thresholds (MPTs) and levels of acetylcholinesterase (AChE), free sarcoplasmic calcium (Ca(2+)), adenosine 5'-triphosphate (ATP), adenosine 5'-monophosphate (AMP), substance P (SP), and calcitonin gene-related peptide (CGRP) in rat muscle TrP tissue. Male Sprague Dawley rats (n = 32) were randomly divided into four groups: control, TrP, acupotomy, and lidocaine injection. Enzyme-linked immunosorbent assays were used to measure AChE, and free sarcoplasmic Ca(2+) concentrations were determined by fluorescent staining with Fura-2 AM; high-performance liquid chromatography was used to measure ATP and AMP, and SP and CGRP were evaluated by immunohistochemistry. Compared with the control group, free sarcoplasmic Ca(2+), AMP, SP, and CGRP were higher in the model group, while MPT, AChE, and ATP were lower. Treatment with acupotomy or lidocaine injection reduced free sarcoplasmic Ca(2+), SP, and CGRP and increased MPTs and AChE levels compared with the model group. However, only acupotomy also led to decreased AMP and increased ATP levels relative to the model group. We conclude that acupotomy can alleviate energy crises at TrPs.

PubMedSearch : Zhang_2020_Evid.Based.Complement.Alternat.Med_2020_5129562
PubMedID: 32190087

Related information

Citations formats

Zhang Y, Du NY, Chen C, Wang T, Wang LJ, Shi XL, Li SM, Guo CQ (2020)
Acupotomy Alleviates Energy Crisis at Rat Myofascial Trigger Points
Evid Based Complement Alternat Med 2020 :5129562

Zhang Y, Du NY, Chen C, Wang T, Wang LJ, Shi XL, Li SM, Guo CQ (2020)
Evid Based Complement Alternat Med 2020 :5129562